throbber
To:
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`AAH Holdings LLC (ptodocket@arelaw.com)
`
`U.S. TRADEMARK APPLICATION NO. 86895019 - NPAID NON-PHARMACEUTICAL - 3855/6
`
`1/9/2017 12:55:57 PM
`
`ECOM116@USPTO.GOV
`
`Attachment - 1
`Attachment - 2
`Attachment - 3
`Attachment - 4
`Attachment - 5
`Attachment - 6
`Attachment - 7
`Attachment - 8
`Attachment - 9
`Attachment - 10
`Attachment - 11
`Attachment - 12
`Attachment - 13
`Attachment - 14
`Attachment - 15
`Attachment - 16
`Attachment - 17
`Attachment - 18
`Attachment - 19
`Attachment - 20
`Attachment - 21
`Attachment - 22
`Attachment - 23
`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
`
`U.S. APPLICATION SERIAL NO. (cid:160) 86895019
`
`(cid:160)M
`
`ARK: NPAID NON-PHARMACEUTICAL
`
`CORRESPONDENT ADDRESS:
`(cid:160)(cid:160)
`(cid:160)(cid:160) (cid:160) (cid:160) MAX VERN
`(cid:160)(cid:160)
`(cid:160)(cid:160) (cid:160) (cid:160) AMSTER, ROTHSTEIN & EBENSTEIN LLP
`(cid:160) (cid:160) (cid:160)(cid:160)(cid:160)(cid:160) 90 PARK AVENUE
`(cid:160) (cid:160) (cid:160)(cid:160) (cid:160) (cid:160) NEW YORK, NY 10016
`(cid:160)(cid:160)(cid:160)(cid:160)
`
`APPLICANT: AAH Holdings LLC
`
`(cid:160) (cid:160)(cid:160)
`
`CORRESPONDENT’S REFERENCE/DOCKET
`
`*86895019*
`
`CLICK HERE TO RESPOND TO THIS
`LETTER:
`http://www.uspto.gov/trademarks/teas/response_forms.jsp
`
`VIEW YOUR APPLICATION FILE
`
`(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) (cid:160) (cid:160)
`(cid:160)(cid:160)(cid:160)
`
`(cid:160) 3855/6
`
`NO:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`CORRESPONDENT E-MAIL ADDRESS:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`ptodocket@arelaw.com
`
`OFFICE ACTION
`
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`

`

`STRICT DEADLINE TO RESPOND TO THIS LETTER
`TO AVOID ABANDONMENT OF APPLICANT’S TRADEMARK APPLICATION, THE USPTO MUST RECEIVE APPLICANT’S
`COMPLETE RESPONSE TO THIS LETTER WITHIN 6 MONTHS OF THE ISSUE/MAILING DATE BELOW.
`
`(cid:160)I
`
`SSUE/MAILING DATE: 1/9/2017
`
`THIS IS A FINAL ACTION.
`
`This letter responds to applicant’s communication filed on November 23, 2016, in which applicant argued against the previously issued
`Disclaimer Requirement.(cid:160) Please note, the examining attorney has carefully considered applicant’s arguments and finds them unpersuasive to
`overcome the requirement.(cid:160) Therefore, the Disclaimer Requirement is hereby made FINAL.
`
`(cid:160)D
`
`isclaimer Requirement – FINAL ACTION
`
`(cid:160)I
`
`it must disclaim the wording “NON-
`that
`the examining attorney advised applicant
`n the initial office action dated May 24, 2016,
`PHARMACEUTICAL ANTI-INFLAMMATORY DEVICE” because it merely describes the nature, feature and function of applicant’s goods,
`and thus is an unregistrable component of the mark.(cid:160) See 15 U.S.C. §§1052(e)(1), 1056(a); In re Steelbuilding.com, 415 F.3d 1293, 1297, 75
`USPQ2d 1420, 1421 (Fed. Cir. 2005); In re Gyulay, 820 F.2d 1216, 1217-18, 3 USPQ2d 1009, 1010 (Fed. Cir. 1987); TMEP §§1213,
`
`1213.03(a).(cid:160)(cid:160)
`Specifically, the applicant’s mark is “ NPAID NON-PHARMACEUTICAL ANTI-INFLAMMATORY DEVICE” for “High frequency
`electromagnetic therapy apparatus.” (cid:160) The previously attached evidence shows the term “non” refers to “not” and “pharmaceutical” means “of
`or relating to pharmacy or pharmacists; a pharmaceutical product or preparation.” As such, the term “non-pharmaceutical” refers to something
`not of a pharmaceutical nature. Furthermore, the term “anti-inflammatory” refers to “preventing or reducing inflammation.” (cid:160) The term
`“device” means “an object designed and manufactured to perform one or more functions.” (cid:160) Please see definitions attached in initial Office
`action.(cid:160) Therefore, the wording merely describes the nature, feature and function of applicant’s goods. (cid:160) That is, applicant provides non-
`pharmaceutical devices that reduce/prevent inflammation.
`
`(cid:160)I
`
`n its response applicant agrees to the disclaimer of “ANTI-INFLAMATORY”. (cid:160) However, applicant argues “that it takes an extraordinary effort
`of imagination for NON-PHARMACEUTICAL ANTI-INFLAMMATORY DEVICE to be understood as used on goods encompassed by the
`application.(cid:160) The mark in its entirety does not immediately call to mind such goods, and it is no more than suggestive of the goods in the present
`specification, rather than merely descriptive.” (cid:160) Applicant further argues that “[r]egarding the term NON-PHARMACEUTICAL in particular,
`Applicant respectfully submits that it was uniquely adopted for use in conjunction with mark’s other elements on or in connection with the listed
`goods, and that there are no other third party marks on the USPTO record that include the “NON-PHARMACEUTICAL” wording. (cid:160) This is
`additional probative evidence establishing that it is not merely descriptive, but, at the utmost, suggestive.”
`
`(cid:160)H
`
`owever, a mark is suggestive if some imagination, thought, or perception is needed to understand the nature of the goods and/or services
`described in the mark; whereas a descriptive term immediately and directly conveys some information about the goods and/or services.(cid:160) See
`Stoncor Grp., Inc. v. Specialty Coatings, Inc., 759 F.3d 1327, 1332, 111 USPQ2d 1649, 1652 (Fed. Cir. 2014) (citing DuoProSS Meditech Corp.
`v. Inviro Med. Devices, Ltd., 695 F.3d 1247, 1251-52, 103 USPQ2d 1753, 1755 (Fed. Cir. 2012)); TMEP §1209.01(a).(cid:160) Here, there is no
`imagination needed to understand that applicant provides non-pharmaceutical devices that reduce/prevent inflammation.
`
`(cid:160)P
`
`lease see evidence which includes websites from the following:
`
`(cid:160)C
`
`DC which states:(cid:160) Nonpharmaceutical Interventions (NPIs)(cid:160) are actions, apart from getting vaccinated and taking medicine, that people and
`communities can take to help slow the spread of illnesses like pandemic influenza (flu). NPIs are also known as community mitigation strategies.
`When a new flu virus spreads among people, causing illness worldwide, it is called pandemic flu. Because a pandemic flu virus is new, the
`human population has little or no immunity against it. This allows the virus to spread quickly from person to person worldwide. NPIs are among
`the best ways of controlling pandemic flu when vaccines are not yet available.
`
`(cid:160)D
`
`rugs.com which states:(cid:160) Non-pharmacological therapies are ways to decrease pain in addition to medicine. Each person may respond to these
`therapies differently.
`
`(cid:160)N
`
`CBI and Public Health Emergency – which both use the term “non-pharmaceutical … devices” descriptively for apparatus/devices that do not
`require administering of medicine/pharmaceuticals.
`
`(cid:160)A
`
`rticle discussing applicant’s products that states the following:
`
`(cid:160)T
`
`hrough its targeted Pulsed Electromagnetic Field Device, the ASSISI LOOP has been embraced by the veterinary community as an adjunct or
`alternative therapy to treat a range of conditions in dogs, cats and horses. The Loop, whose technology is FDA-cleared, is a NPAID (Non-
`
`(cid:160)(cid:160)
`(cid:160)
`

`

`Pharmaceutical Anti-Inflammatory Device) prescribed by veterinary professionals to treat orthopedic injuries, degenerative neurological
`conditions, post-surgical pain and swelling, osteoarthritis and other inflammatory conditions and wounds.
`
`(cid:160)"
`
`We understand that compliance and convenience can impact the right treatment for a pet. That is why we are excited to
`help make the healing process easier with the launch of our new LOOP-AID accessory line," said John Wilkerson, PhD,
`Chief Executive Officer of Assisi Animal Health. "The ASSISI-HERO Torso Wrap is the first product in the line and helps to
`
`make the treatment process easier for all parties involved."(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`The Torso Wrap is a lightweight, durable garment that the LOOP attaches to during treatment.(cid:160) The Wrap is designed to stay on the pet for the
`duration of their daily treatments and has adjustable Velcro attachments for securing the LOOP in different areas of need. This makes the
`treatment more convenient for the pet owner and allows more mobility for the pet.
`
`(cid:160)T
`
`he Wrap comes in seven sizes, ranging from XXS-XL, and has a size specifically for long-low breeds that frequently suffer from severe back
`
`issues.(cid:160) Made of 87 percent nylon and 13 percent spandex, the Torso Wrap is washable and dries quickly on a flat surface.(cid:160)(cid:160)
`
`Therefore, the disclaimer requirement is hereby made final.
`
`(cid:160)P
`
`lease note, the Office can require an applicant to disclaim an unregistrable part of a mark consisting of particular wording, symbols, numbers,
`design elements or combinations thereof.(cid:160) 15 U.S.C. §1056(a).(cid:160) Under Section 2(e) of the Trademark Act, the Office can refuse registration of an
`entire mark if the entire mark is generic, merely descriptive, deceptively misdescriptive, or primarily geographically descriptive of the services.(cid:160)
`15 U.S.C. §1052(e).(cid:160) Thus, the Office may require an applicant to disclaim a portion of a mark that, when used in connection with the services, is
`merely descriptive, deceptively misdescriptive, primarily geographically descriptive, or otherwise unregistrable (e.g., generic).(cid:160) TMEP
`§1213.03(a).(cid:160) Therefore, applicant must disclaim “BLOG” because such wording appears to be descriptive as a feature of applicant’s services.
`
`(cid:160)F
`
`ailure to comply with a disclaimer requirement can result in a refusal to register the entire mark.(cid:160) TMEP §1213.01(b).
`
`(cid:160)A
`
`“disclaimer” is a statement that applicant does not claim exclusive rights to an unregistrable component of a mark.(cid:160) A disclaimer does not
`affect the appearance of the applied-for mark.
`
`(cid:160)T
`
`he computerized printing format for the Office’s Trademark Official Gazette requires a standardized format for a disclaimer.(cid:160) TMEP
`§1213.08(a)(i).(cid:160) The following is the standard format used by the Office:
`
`No claim is made to the exclusive right to use “ NON-PHARMACEUTICAL ANTI-INFLAMMATORY DEVICE” apart from the
`mark as shown.
`
`(cid:160)S
`
`ee In re Owatonna Tool Co., 231 USPQ 493 (Comm’r Pats. 1983).
`
`(cid:160)C
`
`onclusion – Telephone or Email Response Suggested
`Applicant is encouraged to telephone or e-mail the assigned trademark examining attorney to resolve the issues raised in this Office action by
`examiner’s amendment. Although a formal response may never be submitted by e-mail, an applicant may communicate informally by phone or
`e-mail with the trademark examining attorney to agree to a proposed amendment to the application that will immediately place the application in
`condition for publication for opposition, issuance of a registration, or suspension. See TMEP §707.
`
`(cid:160)P
`
`roper Response to Final Action
`
`Applicant must respond within six months of the date of issuance of this final Office action or the application will be abandoned.(cid:160) 15 U.S.C.
`§1062(b); 37 C.F.R. §2.65(a).(cid:160) Applicant may respond by providing one or both of the following:
`
`(1)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`(2)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`A response that fully satisfies all outstanding requirements and/or resolves all outstanding refusals.
`
`An appeal to the Trademark Trial and Appeal Board, with the appeal fee of $100 per class.
`
`(cid:160)3
`
`7 C.F.R. §2.63(b)(1)-(2); TMEP §714.04; see 37 C.F.R. §2.6(a)(18); TBMP ch. 1200.
`
`(cid:160)I
`
`n certain rare circumstances, an applicant may respond by filing a petition to the Director pursuant to 37 C.F.R. §2.63(b)(2) to review
`procedural issues.(cid:160) TMEP §714.04; see 37 C.F.R. §2.146(b); TBMP §1201.05; TMEP §1704 (explaining petitionable matters).(cid:160) The petition fee
`is $100.(cid:160) 37 C.F.R. §2.6(a)(15).
`
`(cid:160)(cid:160)
`
`TEAS PLUS OR TEAS REDUCED FEE (TEAS RF) APPLICANTS – TO MAINTAIN LOWER FEE, ADDITIONAL
`REQUIREMENTS MUST BE MET, INCLUDING SUBMITTING DOCUMENTS ONLINE:(cid:160) Applicants who filed their application
`
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`

`

`online using the lower-fee TEAS Plus or TEAS RF application form must (1) file certain documents online using TEAS, including responses to
`Office actions (see TMEP §§819.02(b), 820.02(b) for a complete list of these documents); (2) maintain a valid e-mail correspondence address;
`and (3) agree to receive correspondence from the USPTO by e-mail throughout the prosecution of the application.(cid:160) See 37 C.F.R. §§2.22(b),
`2.23(b); TMEP §§819, 820.(cid:160) TEAS Plus or TEAS RF applicants who do not meet these requirements must submit an additional processing fee of
`$50 per international class of goods and/or services.(cid:160) 37 C.F.R. §§2.6(a)(1)(v), 2.22(c), 2.23(c); TMEP §§819.04, 820.04.(cid:160) However, in certain
`situations, TEAS Plus or TEAS RF applicants may respond to an Office action by authorizing an examiner’s amendment by telephone or e-
`
`mail without incurring this additional fee.(cid:160)(cid:160)(cid:160)
`
`/tfrazier/
`Tamara Frazier
`Trademark Attorney
`Law Office 116
`(571) 272-8256
`tamara.frazier@uspto.gov
`
`(cid:160)T
`
`O RESPOND TO THIS LETTER: (cid:160) Go to http://www.uspto.gov/trademarks/teas/response_forms.jsp. (cid:160) Please wait 48-72 hours from the
`issue/mailing date before using the Trademark Electronic Application System (TEAS), to allow for necessary system updates of the application.(cid:160)
`For technical assistance with online forms, e-mail TEAS@uspto.gov.(cid:160) For questions about the Office action itself, please contact the assigned
`trademark examining attorney.(cid:160) E-mail communications will not be accepted as responses to Office actions; therefore, do not respond to
`this Office action by e-mail.
`
`(cid:160)A
`
`ll informal e-mail communications relevant to this application will be placed in the official application record.
`
`(cid:160)W
`
`HO MUST SIGN THE RESPONSE:(cid:160) It must be personally signed by an individual applicant or someone with legal authority to bind an
`applicant (i.e., a corporate officer, a general partner, all joint applicants).(cid:160) If an applicant is represented by an attorney, the attorney must sign the
`
`response.(cid:160)(cid:160)
`PERIODICALLY CHECK THE STATUS OF THE APPLICATION: (cid:160) To ensure that applicant does not miss crucial deadlines or official
`notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at
`http://tsdr.uspto.gov/. (cid:160) Please keep a copy of the TSDR status screen. (cid:160) If the status shows no change for more than six months, contact the
`Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. (cid:160) For more information on checking
`status, see http://www.uspto.gov/trademarks/process/status/.
`
`(cid:160)T
`
`O UPDATE CORRESPONDENCE/E-MAIL ADDRESS:(cid:160) Use the TEAS form at http://www.uspto.gov/trademarks/teas/correspondence.jsp.
`
`(cid:160)(cid:160)
`

`

`mun //wwwnmewswire cum/newweieases/assisranimariwaimiaunch2s—iuun~au1—a::c2ssui —|irier3E||J3E|9EE3 html
`Ell/|JBf2E|l71'l 54 4E AM
`
`NEVVS
`
`NEWS ll] FOCUS
`
`BUSWIGSS & M0|'l€‘f
`
`SCIENCE 5| T3Ci'I
`
`LITCSNIE St Health
`
`PDIICY Si FUUIIC Interest
`
`PHONE St CUWUIS
`
`PR NGWSW I re
`a cislcu company
`
`News
`
`Sotutions
`
`Resources
`
`Search
`
`News in Focus
`
`Business & Money
`
`Science & Tecii
`
`Lifestyle Si Health
`
`Policy & Publli.‘ interest
`
`People &CLllture
`
`
`
`Assisi Animal Health Launches
`LOOP—A|D® Accessory Line
`
`ASSISI-HERO TORSO WRAP FIRST TO MAKE HEALING EASY
`
`/\ I
`!:QS\!i":‘!i!?
`
`NEWS PROVIDED EV
`Aug 05, 2016, 10:22 ET
`WWW"
`
`SHARE Tl-HS ARTICLE
`
`0000000
`
`SAN ANTONIO, Aug 5, 2016 JPRNewswire/ — AVMA convention -- Assisi Animal Health announced today their first product in an
`accessory line, targeted at enhancing Lrealmentwhen using the ASS|Sl LOOP“? The ASSlSl—HERO LODFLAID, designed by Ben
`Blechai CPO, who is Hero Braces‘ Orthotist, was developed to assist in compliance with vetennarians' instnictions, ofler convenience
`tor the pet owners and allow mobility for the pet during treatments
`
`Through its targeted Pulsed Electromagnetic Field Device, the ASSlSl LOOP has been embraced by the veterinary community as an
`adjunct or alternative therapy to treat a range of conditions in dogs‘ cats and horses The Loop, whose technology is FDA—i:|eared, is
`a NPAID (Non—PharmaceuticaI Anti—lnt'lammatory Device) prescribed by vetennary professionals to treat orthopedic Injllflefi‘
`degenerative neurological conditions‘ postsurgical pain and swelling, osteoarthritis and other inflammatory condrtions and wounds,
`
`"Min i.m<,..rim,i uni rnrnniinnrn -ma rnnnnrwlnnr/V Pdfl nvunrzrt nu.
`
`

`

`mun //wwwninewswire cum/newweleases/asslstammamaaimlaunch2s—luun~au1—a::c2ssuv r|ine—3E||J3E|9EE3 hlml
`Ell/lJBf2E|l71'l 54 4E AM
`
`‘We understand that compliance and convenience can impact the
`right treatment for a pet That is why we are excited to help make the
`healing process easier with the taunch ofour new LOOP—
`AID accessory line," said John Vlfilkerson, PhD, Chiet Executive
`Olficer of Assisi Animal Health. "The ASSlSi—HERO Torso Wrap is
`the first product in the line and helps to make the treatment process
`easier tor all pamm involved,"
`
`The Torso Wrap is a lightweight, durable gannent that the LOOP
`attaches to during treatment The Wrap is designed to stay on the
`pet for the duration of their daily treatments and has adjustable
`Velcro attachments for securing the LOOP in diftexent areas of need,
`This makes the treatment more convenient for the pet owner and
`allows more mobility for the pet
`
`
`
`Dog nixmgrwned iniltiASSISl«HEROTumwin» and ASSISI i.ooP. lwgineauiunun Image
`available uwri mm!)
`
`The Wrap comes in seven sizes, ianging from XXS—XL and has a
`size specifically for |ong—|ow breeds that frequently sufier from
`severe back issues Made at B7 oercent nvlon and 13 percent soandex, the Torso Wran is washable and dries oiiicklv on a flat
`surface
`
`The ASSISI HERO Torso Wrap will be available for purchase eany this tall, For more information, vism our
`website: www assisianimalhealtlicom
`
`About Asslsl Animal Health
`
`Assisi Animal Health was acquired in 2013 oy John Wilkerson, a successful medical industry entrepreneurand life science growth
`investor Assisi Animal Health is a science-based company specializing in ofienng clinical therapeutic solutions to veterinary
`professionals The Assisi Loop is sold directly only to veterinary pmfessionals or by veterinary prescription to pet owners, The
`company helps veterinary professionals and pet owners collaborate in delivenng the optimal level oi care to animals For more
`
`

`

`mun //wwwnmewswire cum/newweieases/assisiammaiiwaimiaunch2s—iuun~ai-taccessuv —|in2r3E|E|3E|9EE3 mmi
`EH/|JBf2E|17 1'1 54 4E AM
`
`inforrnatiun_ visit Assisi Animai Heaith, Folluw Assisi Animal Health on Twitter @assisi|oop or Facebook
`
`Phom — imp //piiolusprriewswire com/prnh/20160805/395948
`Lugu _ hllp I/piiulo: piiiewawiie Lulll/plllll/20150805/3959BC|LCGO
`
`Innann OHli:lErIrina,AFR Feuawnun
`|gPrNImiei'i@tjPrlnnvrIPl rnm
`517<i:i+at:n.x212<5s7qi7n
`
`mm comm:
`Kane Dxlariki
`Kflijiir mmpm.uar@mmmmainmm ./In
`4isa1+24anam ms
`
`SOURCE Assisi Animal Health
`
`Relaied Links
`nap‘!/mvw assisianimaihcaith com
`
`Also from this source
`OCT05‘ 2011110115 ET
`Assisi Loop Helps Pe1s In Pain
`
`
`
`Explore
`lviore news reaeases in simiiai
`topics
`Hnucs-hnlrl, Cnnciimslr R. Cncrnsiirs;
`Medi:al Equipmeni
`Medical Phalrnacallitals
`
`

`

`mun //wwwnmewswwe cum/newweweases/asswan»mamaawwannch2s—\uun~au1—a::c2ssuv rIme—3EIIJ:-M9553 mm!
`EH/|JBf2E|17 1'1 54 4E AM
`
`Ammals SPSIS
`New Pruuucls 8: Services
`
`Assisi Animal Health Launches LOOP-A|D®
`
`Youjust man.
`
`Accessory Line
`NEWS I-'HUVIUtL) HY
`
`Aug 05, me, 10:22 ET
`““"’"
`
`SHARK’: IHIS AH HULI:
`
`O O C C O O 0
`
`hllp .//www pmewswwe com/newsreieasesiasslsranima|—hea\th—Launches—|oop—a1d—atce5sory—|Ine—3D[B09883 html
`
`l
`
`
`
`Sen/uses
`
`

`

`nuns /fwww cu: -1uv/nunpnannaceulleal—lnlervenlluns/
`
`En/ma/2m7 12 D2 14 PM
`
`SKI dlrectl to Search
`
`\..IJ\_
`'
`' '
`' '
`CDC 24/7 Saving Llves, Pvoleclirlg People”
`
`
`
`JA 7 INDEX
`
`onpharmaceutlcai Interventlons (NPIs)
`
`Froucl yaurself and omers fmlll gaming and soleauing respiratory illnesses llke palldemll: llu.
`ND!IpIIfl|'|'lIECE|lfiE| Il'IIEI'VEI'|Ii°fl5 INFIS) EVE HCLKIHS‘ EIDZI1 WDITI gelllrlg VGCEIIIHIGG and taking l'lI€fliE|lIE_ "I31 DSODIE and COIWYIUNIIES can lake [0 HSVD SVOWIHE SDVEBG GT IIIIIESSSS HKG
`pandemic Influenza (llll) Nms are also known as cemmunny mILlga1ion stlalegles When a new llu wrus spreads among people, causlng lllness wnmwlue, ll ls called palldernlc 1Iu, Because a
`pandemic flu vlms IS new‘ has human populanon nas lmle or no lmmunfty agalnsl ll, Tllls allow me was to spread qulckly from person lo pelsarl worldwide NPls are among me besl ways cf
`CGMTDEHHQ pandemic "II when VECEIIIES are 1101 YEE HVBIIZDIE
`Tnls WEDSFIS provlaes Be:
`an makers‘ planIIEIS, am: pumlc health pmtessscllals wllll educallmlal louls, resources. pandemic nlarlnlng gulaes, l: rleckllsls, and select research about me types
`of NPIS and how they work in difielfilll Seflings,
`FIU Prevention
`
`TQOIS and RESOURCES
`
`

`

`mung /fwww can -1uv/nnnphavmacemma\—m1ervermuns/
`
`EH/ma/2m712 D2 14 PM
`
`At Home
`
`At School
`
`
`Dwlslun at Glunal Migration and Quaranllne
`
`@ EDUCATIONAL MATERIALS
`
`D
`E PLANNING GUIDANCE AND CHECKLISTS
`
`I!-—|
`
`PUBLISHED RESEARCH
`
`mam Lmks
`
`Seasonal Influenza (Flu)
`Ofiice (‘If Public Health Preparedness and Response
`Heanny Smuuls
`Adnlescenl and Schunl Heallh
`Wfllefl Sanitation &El|\lII('I|'IlYI€maI']—lEI3I€G Hygiene
`
`

`

`mung /fwww can -1uv/nnnphavmacemma\—m1ervermuns/
`
`EH/ma/2m712 D2 14 PM
`
`
`
`Envimnmemal Nplsz Surface meaning
`
`Personal NPISZ Everyday Preventive
`Actions
`
`Community NFIS: Flu Prevention In
`Community Seitings
`
`Page |.':l51l'E1l|EINEd. Aplil 5, 2016
`Page last updaled, Aplil 5, 2015
`Cliflfifll SHINE" CEMEFS [Of Di5%S€ Cflmlfli and PTEVEHIDII
`Namnal Ceflleffm EmBf(!]I'I,fl and ZDOIIUIK: Infeciluus Diseases (NCEZID)
`Division of Global Migraliuil and Quaranline (DGMQ)
`
`LEI'iD&
`
`Aboul CDC
`JUIE
`Funding
`
`'L@E']
`Pollzies
`Privacy
`
`FDIA
`
`M0 Fear Nil
`
`DIG
`
`’164]|] CIn10rI RnaaAllama, GA 3|)32H4fl27 USA
`B00«CDE‘/INFO (BGCL2324536), '|TY B3&232«634B
`Emaii CDC—|NFD
`
`U S, Depanmenl 0! Health 8: Human SEWKEGS
`HHSIOpErI
`USAQOV
`
`

`

`iiiuns /fwww drums Cum/answers/riEih—llhelmaizeutlceHIElrkrelievlnfl»Mei/iE2—fl1EIVIEtE—3lE3319 titml
`Eli/|JBf2E|i712 29 22 PM
`
`§’SlP‘ C°"‘Ef!E
`
`
`e,
`% Drugs.com
`Bmwseallrnedicatlolis Aec DEFGHIJKLM NOFQRSTUVWXVZ
`KIIOW more.Besure.
`DRUGS A-Z
`PlLL l|'.IENTtF|ER
`iM1'i=.RAo'nons CHECKER
`NEWS
`Q a A
`
`a
`AdvancedSearI:h
`APPS
`PRO EDITION
`
`MORE
`
`SUB0XONE® Sublmgual F1l1n CII
`Enter you zip code and find a decrm nearby mm can p!c\‘1dE help and treatment
`Go to suboxoue com
`
`Home
`
`a 34 A
`
`Questions
`
`Can non-pharmaceutical Dilh
`
`
`
`sign In or Register
`
`Can non-pharmaceutical, pain relieving
`
`device provide long term effect w/0
`
`Cymbalta side effects?
`Asked
`14 NOV 2016 by EHCEHHH
`Active
`17' Nov 2016
`Topics
`cymbalta, osleuamirius, pain, back pain, fibrumyailnia. chronic pain, sine enect, pharmacy
`Hi, l was inst going through the reviews and thought l could ask feedback about a new rionphannaceutical,
`pain relieving device providing long term effectiveness without harmful side effects
`l’m doing preliminary research on pain relieving devices and treatment with the iment to gelfeedback on
`experiences as well as, share information about a new product in deveiopment to determine if potential users
`would be interested in the comfort and freedom this new product will bring.
`The product is like a next generation brace, with the ability to deliver naturai ingredients that are scientifically
`demonstrated to relieve pain, and administer two other key functions that are individually clinically proveri to
`provide longer lasting relief, This device puts the three powerhouses together in one system to create the
`ultimate solution to both chronic and acute pain,
`I6 ma. nrrvinur-O .-.,....,. in rvvgrtrnl um nu 5...-.. M ....u...,. On ffil i5’)
`
`
`
`3 Signs Vuu May Have Fatty Liver
`[wamh Now]
`
`CON ER UPDATES
`
`E3);
`
`
`
`DEPIEESEOI1: ;DA4PP,m,g1 M!dicmi°ns may HE“,
`Dealing With ADHD: What You need 10 Know
`Making Decisions tor Your Health: Getting the
`Info You Need
`
`bx
`SUBOXONEC
`Sublingual
`Film CH
`Enter your zip
`code and End a
`doctor nearby who
`can provide help
`and tneatnlent.
`:uhemz surzi
`

`
`

`

`mung /fwww drums CElm/anSWEVS/nun’FHarmsEELHIEEH33VH2‘tEvtHfl>dE\/iEErFJVEIVIdE—3tE3319 iiimi
`EH/|JBf2E|1712 29 22 PM
`
`If this product came to market, would anyone be willing to try it’?
`What would your decision piuness to buy or nut to buy it took like?
`
`Enterymir zip nude and flnd a uocmi nearby WIID can provide help and
`ltEaIl1|eltL G010 suboxdne cam
`SUBOXONE® Sublingual Film CII
`we! this Ques on
`
`@
`
`R
`
`rt
`
`SW
`
`F
`
`i
`51°”
`
`Responses (1)
`
`
`’ 1‘.
`eeiiucii-issr
`Grace; This IS something you're going to have to talk to yourdoctor about it depends on earn person I have
`used several diflerent electronic devices wrtnout much luck and some Deonle have pretty good results but
`everyone is diffeient but you don't want to change without your decmrs advice Ctiiick1957
`Votes: +0
`Comment
`Vote up
`
`Report
`
`[Watch Now]
`
`2 K _an_.‘.
`3 Signs You May Have Fatty iver
`
`FDA: cimaiig-Edge Tenhlialogy Sheds Ligiii on
`Antibiotic Resistance
`More FDA updates
`
`Support smups
`Tap we gmups
`Emups by medication
`Groups hy condition
`
`My Fiieiiiis
`You must Sign into View your fnends
`View lop members
`Find a member
`
`My ouestiuiis 24. Answers
`VIEW lamest questions
`Search for answers
`Ask a IILIESIIOII
`
`Enter your zip
`code and End a
`doctor neaflyy who
`can pmxidra help
`and treaauiani.
`iuimxmi: cum
`
`(9
`
`Ema your zip
`codcandfinda
`
`

`

`mung /fwww drums numfanswers/nunnhavmanzeuilcawain—reiievinuwievmerrlruvlderfliE3319 him!
`Eli/|JBf2E|1712 29 22 PM
`
`$EHIBSICITI
`
`
`Free Drug Discount Card
`Save up to 80% off on your presc: iptions.
`
`_W_N____M W Downluadnuw
`
`Further Information
`- Cymbalta Information for Consumers
`- Cymhalca Informaiion for Heaithcare Professionals (includes dosage details)
`- Side Errects of Cymbalta (detailed)
`
`Search for questions
`Strli making for answers’? Try searching iur whai you seek or ask your own question,
`
`
`
`
`
`Why Doctors In The Know No
`Longer Prescribe Metformin
`
`mm: mm Lulu a
`doctor nearby who
`can proxide help
`and ireatrneni.
`iuhnxnne Cum
`
`@
`
`Enter your zip
`code and End a
`doctor neaflzy who
`can pmxidc help
`and 1reatn1ent.
`mhuxnne cum
`
`(9
`
`

`

`mung /fwww drums cum/answars/nu»phavmaceuuca\—pam—re\xewnudevmernruvnderawE3319 him!
`EH/|JBf2E|1712 29 22 PM
`
`._....=,...
`
`. ...........- ................
`
`.1
`
`utMore)
`
`«$12,493
`
`Fffflioiétl
`
`
`
`Similar Questions
`What is the long term effect between cymbalta and topiramate?
`Posted 4 Apr 2013 2 answers
`
`Good afternoon, I was put on 30 mg. Cymhalta and then increased to 60 mg.but the sexual
`side effects
`Posxeu 17 Feb 24:14 2 answers
`
`is Cymbaita good for fibromyalgia?
`Fasten 21 Feb 21:14 5 answers
`
`Embeda - Side effect
`I101?
`PC5190 9 Dec 2DI§
`1 answer
`
`
`
`stant death is listed in other pharmaceutical sites but that term is
`
`Gahapenfin - Got diagnosed with fibromyalgia what are Cymbaita had bad side effects
`DTDKE OUT In?
`Posted 14 Sep 2016
`1 answer
`
`Erlleryour zip code and ma 2 oactur nearby who can provide help and
`IreaLrnenL Ga ID suhoxaneuzm
`SUBOXONE® Sublingual Film CII
`

`
`Entcr your zip
`code and End a
`doctor neaflyy who
`can provide help
`and treatrnerll.
`suhuxnne com
`
`(9
`
`Enter your zip
`code and End a
`doctor nearby who
`can profide help
`
`

`

`mung /fwww drums Cumfanaware/nunllhevmanzeulmeHieVH2!u3vmu»rievme—rIvuVId2r31E3319 mm!
`EH/|JBf2E|1712 29 22 PM
`
`
`
`
`
`may;-zen
`
`
`
`F5‘;
`“Urn
`
`.5:
`9:3!
`
`M
`0'»!W
`
`A G? ®
`:2;
`..::..
`
`Drugs.com Mobile Apps
`The easieslway to lookup drug infunnation, idenlify pills, check interactions and set up
`your own pemorial medication records, Available for Android and IDS devices
`
`Explore Apps
`
`can pumu: imp
`and treaimam.
`submuecem
`

`
`SUPPORT
`Help Center
`Frequent Queslinns
`siiemap
`Contact us
`
`ABOUT
`About Dmgsmm
`Advertising Policy
`comm Submissions
`Dlug:.:orn slog
`
`TERMS 8. PRIVACY
`Editorial Policy
`Privacy Policy
`Telllis 01 Use
`Anrihuhan & citation:
`
`CONNECT
`
`mhoxoue cum
`
`Subscribe [0 receive email nolifitatlons
`whenever new amcles are publishes.
`
`Drugscom provides accurale arm independent mformalxon on more man 24,000 pres:np1ion druqs‘ overelhemunier mediunes and nalum products, This material is provided for
`EULICBWOHEN HUIDDSBS (MW EHO I5 I701 Intended TD! meui::a\ HUWCE‘. UVBQIVOSIS DI UBEITFIEHI Data SUUICES IRCIUGE M}CfUlT?€UeX® (UDUSIEU NOV WEI. 2015). Cerner MLlH|l|'!I'"' (UDUGIEG NOV
`am 2015), Vtlullers Ksuwerm (updated Nov am zma) and others To mew content sources and aflnbullons piease relertu ouredilonal gym!
` We tummy min the HDNcude standard Fm
`TRUST!-F
`:uuH.d Pllvaiy
`urustwsmhy heablh miormatmn —\/erfl here
`
`Cuuynuhte 2u:)EL2m7 Drugs com
`AH nghts reserved
`
`
`
`P M Canines
`
`

`

`mung /fwww drums Cum/CI}/nun—nharmacuInuii:aIrDain—manawem2nt—Ih2raniesJur—aduIIs mml
`EH/|JBf2E|I712 29 SE PM
`
`% Drugs.com
`Bmwse all rnedicafluris Aiac D EFGHIJKLM NOFQRSTUVWXVZ
`KIIOW more.Besure.
`DRUGS A-Z
`FILL IDENTIFIER
`INTERACTIONS CHECKER
`NEWS
`Q & A
`
`5
`Advancedsearch
`APPS
`PRO EDITION
`
`MORE
`
`Learn M an-'
`
`Ella!
`
`Hid:
`
`Hume
`
`CareN<zIes
`
`NorI—uharma:oIugi:aI Pain i‘-«IanauErnenI TneiapiesFui AUIJIIS
`
`Q Print
`
`Share
`
`MORE AEDUT NON-FHARMACOLOGICAL PAIN
`
`Non-pharmacological Pain Management
`Therapies For Adults
`
`mm
`
`P|us,geta
`
`Get help and Ireatinem optiuns rm 3 ducinr neay you G: ti: epic cd2pe*i(I2r*:i:» cw
`Find an Opioid Treatment
`Cam Mm,
`
`» x
`

`
`°"°”I'w E" E5I'a"°'
`
`WHAT YOU NEED TO KNOW:
`
`Depression: FDA-Approved Medications May Heip
`
`Making Decisions in! Your Health: Getting the
`Info You Need
`FDA: cintilig-Eng: Technology sheds Lifilll on
`Antibiotic RESISEIIOE
`“We FDA HFWIES
`
`
`MANAGEMENT THERAPIES FOR ADULTS
`Dealing Will’! ADHD: Wllal YOII Ileedtu Know
`
`
`What are non-pharmacological therapies
`for pain?
`
`Ni)n— harmat OIDCIICEI inera Mes are wavs in decrease Jain i
`
`
`
`Cashback Match”
`‘
`
`

`

` , tomedlcme Each JSDE] n1avre5pr)nd to the!-
`
`her pies differently
`Why is pain control important?
`It pain is not treated, it can decrease your appefite and make it
`dithcult for you m sleep, You may feel that you lack energy or
`the ability to up things. Pain can also affect ypur mood and
`relationships with others Nonpharrriacological therapies may
`help decreme yuur pain or give you more cuntml cweryuur pain This can impruve yuur quality of life
`
`muns /fwww drums cum/ct}/nurknherrrieculnuH:el—Deln—nienadementrtlweremesrlureclults mmi
`Ell/|JBf2E|l7 12 29 SE PM
`
`
`
`Find an Opioid N
`Treatment
`Get help and treatment
`nnoinne Irina 5 An:-C-ruv an-gr
`
`Learn More
`
`Q mg 1;;
`
`
`
`What therapies are nonnally used with medicine to help control pain?
`- Heat: Heat helpsdeciewe pain and muscle spasms, Apply heat to the area for 20 tn 30 minutes every 2
`hours [or as many days as directed
`- Eoe: Ice helps decrease swelling and pain Ice may also help prevent tisue damage Use an ice pack or
`pm crushed ice in a plastic bag. Cover it with a tuwel and place it on the area for 15 lb 20 minutes every
`hour as directed
`- Massage therapy: This may help relax tight muscles and decrease pain
`- Physical therapy: This teaches you exercises ha help improve movement and strength, and to decrease
`pain
`- Transcutarieaus electrical nerve stimulation (TENS): This is a portable, p0cket—-sized, battery—powered
`device that attaches to your skin, It is usually placed over the area of pain It uses I'|'||id‘ safe electrical
`signals In help conhul pain
`- Spinal cord slimulatiloii (SCSI: An electrode is implanted near yourspinal cord during a simple
`procedure The electrode uses mild, sate electrical signals m relax the nerves that cause ynur pain,
`
`

`

`mung /fwww drums i:omfcu/nurvnherrvieeulnuii:el—Deiri—nienauemeritrthereiiiesrtuiedults mmi
`Ell/|JBf2E|l712 29 SE PM
`
`options. Find a doctor near
`you.
`
`opioiddependerice com G)
`
`What other things may help control or reduce pain?
`- Aromatherapy: This is a wayof using scents to relax, relieve stress, and decrease pain, Aromatherapy
`uses oils, extracts, or iragmncas trom iiowers, items, and trees, They may he inhaled or used during
`massages, facials, body wraps, and baths.
`- Guided imagery: This teachesyou ways to put pictures in your mind that

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Try refreshing this document from the court, or go back to the docket to see other documents.

We are unable to display this document.

Go back to the docket to see more.